Abstract：
BACKGROUND: Up to 25% of children and 5.6% of adults in the USA have atopic dermatitis (AD), with substantial impacts on quality of life. Effective control can be challenging despite therapy efforts. The emergence of information and communication technologies (ICT) in AD management prompted this study to assess its impact on self-management. We conducted a meta-analysis to assess outcomes from peer-reviewed clinical trials evaluating the effectiveness of teledermatology, mobile health (mHealth) apps, and electronic devices for managing AD.
METHODS: We searched PubMed, Web of Science, Scopus, and Embase for articles written in English and published until May 2023.
RESULTS: Twelve trials with 2424 participants were selected from 811 studies. A meta-analysis of 1038 individuals reported a mean difference (MD) of -1.57 [95% confidence interval (CI): -2.24, -0.91] for the Patient Oriented Eczema Measure (POEM). A meta-analysis of 495 individuals reported a Dermatology Life Quality Index (DLQI) MD of -0.59 [95% CI: -0.95, -0.23]. Despite heterogeneity (I2 = 47% and I2 = 74%), the impact was significant (P ≤ 0.001). SCORing Atopic Dermatitis (SCORAD) showed an insignificant MD of -0.12 (P = 0.91).
CONCLUSIONS: mHealth applications and telemonitoring show significant improvement in patients\' quality of life (DLQI) and self-management (POEM) but no significant impact on AD severity (SCORAD).
METHODS: We searched PubMed, Web of Science, Scopus, and Embase for articles written in English and published until May 2023.
RESULTS: Twelve trials with 2424 participants were selected from 811 studies. A meta-analysis of 1038 individuals reported a mean difference (MD) of -1.57 [95% confidence interval (CI): -2.24, -0.91] for the Patient Oriented Eczema Measure (POEM). A meta-analysis of 495 individuals reported a Dermatology Life Quality Index (DLQI) MD of -0.59 [95% CI: -0.95, -0.23]. Despite heterogeneity (I2 = 47% and I2 = 74%), the impact was significant (P ≤ 0.001). SCORing Atopic Dermatitis (SCORAD) showed an insignificant MD of -0.12 (P = 0.91).
CONCLUSIONS: mHealth applications and telemonitoring show significant improvement in patients\' quality of life (DLQI) and self-management (POEM) but no significant impact on AD severity (SCORAD).
摘要：
背景：美国高达25％的儿童和5.6％的成年人患有特应性皮炎（AD），对生活质量有重大影响。有效的控制可能是具有挑战性的，尽管治疗努力。信息和通信技术（ICT）在广告管理中的出现促使本研究评估其对自我管理的影响。我们进行了一项荟萃分析，以评估同行评审的临床试验的结果，该临床试验评估了远程皮肤病学的有效性，移动健康(mHealth)应用程序，和用于管理AD的电子设备。
方法：我们搜索了PubMed，WebofScience,Scopus,和Embase的英文文章，直到2023年5月出版。
结果：从811项研究中选择了12项试验，包括2424名参与者。对1038名个体进行的荟萃分析报告，以患者为导向的湿疹测量（POEM）的平均差（MD）为-1.57[95％置信区间（CI）：-2.24，-0.91]。对495名个体的荟萃分析报告皮肤病生活质量指数（DLQI）MD为-0.59[95％CI：-0.95，-0.23]。尽管存在异质性(I2=47%，I2=74%)，影响显著(P≤0.001).SCORing特应性皮炎（SCORAD）的MD为-0.12（P=0.91）。
结论：mHealth应用和远程监测显示患者生活质量(DLQI)和自我管理(POEM)显著改善，但对AD严重程度(SCORAD)无显著影响。
方法：我们搜索了PubMed，WebofScience,Scopus,和Embase的英文文章，直到2023年5月出版。
结果：从811项研究中选择了12项试验，包括2424名参与者。对1038名个体进行的荟萃分析报告，以患者为导向的湿疹测量（POEM）的平均差（MD）为-1.57[95％置信区间（CI）：-2.24，-0.91]。对495名个体的荟萃分析报告皮肤病生活质量指数（DLQI）MD为-0.59[95％CI：-0.95，-0.23]。尽管存在异质性(I2=47%，I2=74%)，影响显著(P≤0.001).SCORing特应性皮炎（SCORAD）的MD为-0.12（P=0.91）。
结论：mHealth应用和远程监测显示患者生活质量(DLQI)和自我管理(POEM)显著改善，但对AD严重程度(SCORAD)无显著影响。
